LENSAR, Inc. (LNSR)
NASDAQ: LNSR · Real-Time Price · USD
11.69
+0.31 (2.72%)
At close: Feb 20, 2026, 4:00 PM EST
11.73
+0.04 (0.34%)
After-hours: Feb 20, 2026, 4:10 PM EST
LENSAR Market Cap
LENSAR has a market cap or net worth of $139.63 million as of February 20, 2026. Its market cap has increased by 3.73% in one year.
Market Cap
139.63M
Enterprise Value
125.64M
1-Year Change
3.73%
Ranking
Category
Stock Price
$11.69
Market Cap Chart
Since October 2, 2020, LENSAR's market cap has increased from $78.01M to $139.63M, an increase of 79.00%. That is a compound annual growth rate of 11.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 139.63M | 0.52% |
| Dec 31, 2025 | 138.92M | 33.78% |
| Dec 31, 2024 | 103.84M | 163.00% |
| Dec 29, 2023 | 39.48M | 21.00% |
| Dec 30, 2022 | 32.63M | -50.28% |
| Dec 31, 2021 | 65.63M | -14.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Electromed | 200.76M |
| Lucid Diagnostics | 187.25M |
| Rapid Micro Biosystems | 172.41M |
| Nano-X Imaging | 168.18M |
| InfuSystem Holdings | 161.67M |
| CVRx, Inc. | 160.76M |
| Inogen | 157.19M |
| Apyx Medical | 155.09M |